Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy

BACKGROUND: Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-23) levels, secondary hyperparathyroidism and chronic kidney disease-mineral bone disorder (CKD-MBD). However dissociated hyperphosphatemia and low serum FGF-23 concentrations have been obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hung-Wei, Hung, Peir-Haur, Hsiao, Chih-Yen, Liou, Hung-Hsiang, Lin, Hsin-Shih, Huang, Tsang-Hai, Jou, I-Ming, Tsai, Kuen-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506049/
https://www.ncbi.nlm.nih.gov/pubmed/26186634
http://dx.doi.org/10.1371/journal.pone.0133278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506049/
https://www.ncbi.nlm.nih.gov/pubmed/26186634
http://dx.doi.org/10.1371/journal.pone.0133278

Ejemplares similares